Kinaxis (OTCMKTS:KXSCF – Get Rating) had its price objective decreased by equities researchers at TD Securities from C$230.00 to C$210.00 in a research report issued to clients and investors on Monday, The Fly reports.
Several other research analysts have also weighed in on the company. Royal Bank of Canada reduced their target price on Kinaxis from C$225.00 to C$200.00 in a report on Thursday, March 3rd. Canaccord Genuity Group reduced their target price on Kinaxis from C$225.00 to C$200.00 in a report on Thursday, March 3rd. Scotiabank cut their price target on Kinaxis from C$213.00 to C$208.00 in a report on Thursday, March 3rd. Stifel Nicolaus cut their price target on Kinaxis from C$235.00 to C$215.00 in a report on Thursday, March 3rd. Finally, National Bank Financial boosted their price target on Kinaxis from C$225.00 to C$250.00 in a report on Tuesday, April 26th. Seven equities research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, Kinaxis currently has an average rating of “Buy” and a consensus target price of $214.22.
Shares of Kinaxis stock traded up $7.38 during trading on Monday, reaching $107.72. 2,700 shares of the company were exchanged, compared to its average volume of 792. Kinaxis has a twelve month low of $100.00 and a twelve month high of $180.40. The business has a 50-day moving average price of $121.52 and a 200-day moving average price of $133.22.
Kinaxis Inc provides cloud-based subscription software for supply chain operations in the United States, Japan, Hong Kong, The Netherlands, South Korea, the United Kingdom, Singapore, France, Ireland, Germany, India, and Canada. It offers Kinaxis, a cloud-based software-as-a-service platform, which provides advanced planning, sales and operations planning, supply and demand planning, inventory management, and command and control center services.
- Get a free copy of the StockNews.com research report on Kinaxis (KXSCF)
- Johnson Outdoors Falls On Bleak Outlook
- Institutional Support For Tyson Foods Is Growing
- Time to Buy These 3 Oversold Mid-Caps
- HCA Healthcare Stock is Ready to Climb Higher
- Mattel Stock is Ready to Catch
Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.